Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Zapico, J.M. (José María) | - |
dc.creator | Acosta, L. (Lourdes) | - |
dc.creator | Pastor, M. (Miryam) | - |
dc.creator | Rangasamy, L. (Loganathan) | - |
dc.creator | Márquez-Cantudo, L. (Laura) | - |
dc.creator | Coderch, C. (Claire) | - |
dc.creator | Ortin, I. (Irene) | - |
dc.creator | Nicolau-Sanus, M. (Maria) | - |
dc.creator | Puchades-Carrasco, L. (Leonor) | - |
dc.creator | Pineda-Lucena, A. (Antonio) | - |
dc.creator | Martínez, A. (Alejandro) | - |
dc.creator | Ramos, P. (Pilar) | - |
dc.creator | Pascual-Teresa, B. (Beatriz) de | - |
dc.creator | Ramos, A. (Ana) | - |
dc.date.accessioned | 2022-01-18T09:04:23Z | - |
dc.date.available | 2022-01-18T09:04:23Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Zapico, J. M.; Acosta, L.; Pastor, M.; et al. "Design and synthesis of water-soluble and potent MMP-13 inhibitors with activity in human osteosarcoma cells". International Journal of Molecular Sciences. 22 (18), 2021, 9976 | es |
dc.identifier.issn | 1422-0067 | - |
dc.identifier.uri | https://hdl.handle.net/10171/62736 | - |
dc.description.abstract | Osteoarthritis is a degenerative disease, often resulting in chronic joint pain and commonly affecting elderly people. Current treatments with anti-inflammatory drugs are palliative, making the discovery of new treatments necessary. The inhibition of matrix metalloproteinase MMP-13 is a validated strategy to prevent the progression of this common joint disorder. We recently described polybrominated benzotriazole derivatives with nanomolar inhibitory activity and a promising selectivity profile against this collagenase. In this work, we have extended the study in order to explore the influence of bromine atoms and the nature of the S1 ' heterocyclic interacting moiety on the solubility/selectivity balance of this type of compound. Drug target interactions have been assessed through a combination of molecular modeling studies and NMR experiments. Compound 9a has been identified as a water-soluble and highly potent inhibitor with activity in MG-63 human osteosarcoma cells. | - |
dc.description.sponsorship | This research was funded by RTI2018-093539-B-I00 (MICIU/FEDER, UE). Laura Marquez- Cantudo thanks Universidad San Pablo CEU and Banco Santander for a Young Researcher contract. Part of the equipment used in this work was co-funded by the Generalitat Valenciana and European Regional Development Fund (FEDER) funds (PO FEDER of Comunitat Valenciana 2014–2020) and Community of Madrid (S2017/BMD-3864). This project received funding from the European Union’s Horizon 2020 research and innovation program under the Marie-Sklodowska-Curie grant agreement number DUALITY 746225. | - |
dc.language.iso | en | - |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/746225/EU | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.subject | MMP-13 inhibitors | - |
dc.subject | Metalloproteinases | - |
dc.subject | Osteoarthritis | - |
dc.subject | Molecular modeling | - |
dc.subject | RMN | - |
dc.subject | Organic synthesis | - |
dc.title | Design and synthesis of water-soluble and potent MMP-13 inhibitors with activity in human osteosarcoma cells | - |
dc.type | info:eu-repo/semantics/article | - |
dc.description.note | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/) | - |
dc.identifier.doi | 10.3390/ijms22189976 | - |
dadun.citation.number | 18 | - |
dadun.citation.publicationName | International Journal of Molecular Sciences | - |
dadun.citation.startingPage | 9976 | - |
dadun.citation.volume | 22 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.